PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Targeting collagen signaling boosts drug delivery in pancreatic cancer

Researchers reveal how blocking collagen signaling enhances treatment response by overcoming fibrotic barriers

2025-12-11
(Press-News.org)

Pancreatic cancer is one of the deadliest malignancies, with survival rates remaining dismally low despite major advances in oncology. One of the key reasons lies in the disease’s unique fibrotic microenvironment—a dense, collagen-rich tissue that acts as a physical and biochemical barrier, preventing drugs from reaching tumor cells effectively.

 

Now, a research team from Okayama University and Tohoku University has uncovered a promising new way to breach this barrier. Led by Assistant Professor Hiroyoshi Y. Tanaka from the Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, the group demonstrated that blocking collagen signaling through the discoidin domain receptor 1 (DDR1) significantly improves the delivery of macromolecular drugs in pancreatic cancer. Their study, published online on October 31, 2025, in the journal Small, highlights a new therapeutic approach to enhance drug effectiveness by dismantling fibrotic resistance mechanisms.

 

The research was spearheaded by Ms. Mayu Ohira and Ms. Moe Kitamura, co-first authors from Okayama University, and carried out in close collaboration with Professor Atsushi Masamune of Tohoku University and Professor Mitsunobu R. Kano of Okayama University. Together, the team investigated how collagen—long considered merely a structural barrier—also acts as a signaling molecule that directly influences fibrosis and drug penetration.

 

“Our findings reveal that collagen signaling, not just its physical density, plays a crucial role in hindering drug delivery,” explained Dr. Tanaka, a co-author from Okayama University, Japan. “By inhibiting DDR1, we can interrupt this signaling cascade, loosen the fibrotic barrier, and enable better access for therapeutic agents.”

 

The team leveraged an advanced three-dimensional cell culture model that replicates the human pancreatic cancer fibrotic barrier. Through this model, they demonstrated that DDR1 inhibition suppresses collagen signaling and enhances the diffusion of macromolecular drugs, such as antibodies and nanomedicines.

 

The study also uncovered an unexpected twist: MEK inhibitors, a class of drugs previously tested in pancreatic cancer, were found to increase collagen I expression, intensifying the fibrotic barrier and reducing treatment efficacy. Remarkably, this fibrosis-promoting effect was reversed when DDR1 signaling was blocked.

 

This newly identified phenomenon, termed ‘therapy-induced exacerbation of the fibrotic barrier,’ may explain why some MEK inhibitor-based therapies have failed in clinical trials. “We found that while MEK inhibitors can attack cancer cells, they also unintentionally strengthen the fibrotic barrier, making drug penetration even more difficult,” said Dr. Tanaka. “Recognizing and countering this effect could fundamentally change how combination therapies are designed for pancreatic cancer.”

 

The researchers emphasized the broader significance of their discovery, noting that a better mechanistic understanding of collagen signaling in fibrosis could lead to new therapeutic strategies across oncology. The team hopes that future studies will validate DDR1 inhibition in clinical settings and pave the way for translational applications in human patients. Looking forward, the team plans to establish combination treatments that simultaneously target tumor cells and their fibrotic surroundings.

 

Beyond pancreatic cancer, the implications of this study extend to other fibrotic diseases where collagen accumulation limits drug access. By redefining collagen’s role as both a structural and signaling component, the researchers believe their work could inform the development of more effective treatments for fibrotic conditions.

 

As pancreatic cancer continues to pose one of the most formidable challenges in modern oncology, this collaborative study offers new hope, illuminating how rethinking fibrosis might finally help life-saving drugs reach their targets.

 

About Okayama University, Japan

As one of the leading universities in Japan, Okayama University aims to create and establish a new paradigm for the sustainable development of the world. Okayama University offers a wide range of academic fields, which become the basis of the integrated graduate schools. This not only allows us to conduct the most advanced and up-to-date research, but also provides an enriching educational experience.

Website: https://www.okayama-u.ac.jp/index_e.html

 

About Dr. Hiroyoshi Y. Tanaka from Okayama University, Japan

Dr. Hiroyoshi Y. Tanaka is an Assistant Professor at the Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Japan. His research spans nanomedicine, biomaterials, vascular and tumor biology, and fibrosis. A recipient of the 2025 Young Investigator Award from the Japanese Cancer Association, he focuses on nanobiotechnology-driven drug delivery and therapeutic innovations for cancer and fibrotic diseases.

 

END



ELSE PRESS RELEASES FROM THIS DATE:

Valvular heart disease is common in cancer patients but interventions improve survival

2025-12-11
Vienna, Austria – 11 December 2025: Valvular heart disease, identified through cardiovascular imaging, is common in cancer patients. Interventions to treat valvular heart disease significantly improved survival.1 These findings were presented today at EACVI 2025, the flagship congress of the European Association of Cardiovascular Imaging (EACVI), a branch of the European Society of Cardiology (ESC). Treatment advances have led to improved survival for patients with cancer. As patients live longer, they are at an increased risk of developing valvular heart disease after successful cancer therapy. Furthermore, it is now well recognised that certain cancer treatments can cause ...

When socially responsible investing backfires

2025-12-11
Socially responsible investors (SRIs) often see themselves as agents of social or environmental progress. They buy into polluting or “dirty” companies believing that their capital can nudge a business toward a cleaner path. Their intention is straightforward: to invest in the bad to make it good. But a new study by finance professors at the University of Rochester, Johns Hopkins University, and the Stockholm School of Economics argues that this logic can backfire. Instead of accelerating environmental reforms, SRIs may unintentionally create incentives for firms to ...

Cuffless blood pressure technologies in wearable devices show promise to transform care

2025-12-11
Statement Highlights: Over the past decade, the number and type of cuffless devices to measure blood pressure, such as smartwatches, rings, patches and fingertip monitors, have increased significantly. However, many personal wearable devices have not been proven to be accurate or reliable for real world use, such as during exercise, sleep or daily activity or after taking medication that affects blood pressure. In addition, variables like arm position, skin color and how recently the device was calibrated, can also affect results and contribute to inaccurate blood pressure measurements. More research and standardized validation protocols are needed before cuffless blood pressure technologies ...

AI-based tool predicts future cardiovascular events in patients with angina

2025-12-11
Vienna, Austria – 11 December 2025: Reduced coronary blood flow, measured with an artificial intelligence-based imaging tool, predicted future cardiovascular events in patients with suspected stable coronary artery disease.1 These findings were presented today at EACVI 2025, the flagship congress of the European Association of Cardiovascular Imaging (EACVI), a branch of the European Society of Cardiology (ESC). Stable coronary artery disease (CAD) refers to the common syndrome of recurrent, transient episodes of chest symptoms, often manifesting as angina. Coronary computed tomography angiography (CCTA) is a non-invasive heart scan that is used as the ...

Researchers map how the cerebellum builds its connections with the rest of the brain during early development

2025-12-11
A team of researchers at the Institute for Neurosciences (IN), a joint center of the Spanish National Research Council (CSIC) and Miguel Hernández University of Elche (UMH), has reconstructed for the first time how the cerebellum establishes its connections with the rest of the brain during the earliest stages of life. The work, published in the journal Proceedings of the National Academy of Sciences (PNAS), describes in detail the phases in which these neural connections emerge, expand, and are refined, offering the first comprehensive map of the development of cerebellar projections across the mouse brain. Although the cerebellum ...

Routine scans could detect early prostate radiotherapy changes

2025-12-11
Daily scans taken during prostate cancer radiotherapy could be repurposed to guide changes to treatment, reducing the risk of side effects, a study suggests. Using AI, scientists found that images originally taken to help position patients for radiotherapy could also identify changes linked to future rectal bleeding as early as one week into treatment. Monitoring these early changes could help doctors decide when to adapt radiotherapy to limit side effects while maintaining cancer control, experts ...

Fairness in AI: Study shows central role of human decision-making

2025-12-11
AI-supported recommender systems should provide users with the best possible suggestions for their enquiries. These systems often have to serve different target groups and take other stakeholders into account who also influence the machine’s response: e.g. service providers, municipalities or tourism associations. So how can a fair and transparent recommendation be achieved here? Researchers from Graz University of Technology (TU Graz), the University of Graz and Know Center investigated this using a cycling tour app from the Graz-based start-up Cyclebee. They conducted research into how the diversity of human needs can be taken into account by AI. ...

Pandemic ‘beneath the surface’ has been quietly wiping out sea urchins around the world

2025-12-11
Sea urchins are ecosystem engineers, the marine equivalent of mega-herbivores on land. By grazing and shredding seaweed and seagrass, they control algal growth and promote the survival of slow-growing organisms like corals and some calcifying algae. They are likewise prey for a plethora of marine mammals, fish, crustaceans, and sea stars. However, when they become overabundant, for example when these predators are overhunted or overfished, sea urchins can also inflict substantial damage to marine habits and form so-called ‘urchin barrens’. Now, a study in Frontiers in Marine Science has revealed that over the last four years, an unrecognized pandemic that ...

Tea linked to stronger bones in older women, while coffee may pose risks

2025-12-11
A new study from Flinders University offers insight into how two of the world’s most popular beverages, coffee and tea, may influence bone health in older women. The research, published in the journal Nutrients, followed nearly 10,000 women aged 65 and older over a decade to explore whether their daily habits of sipping coffee or tea were linked to changes in bone mineral density (BMD), a key indicator of osteoporosis risk. Osteoporosis is a major global health concern, affecting one in three women over 50 and contributing to millions of fractures each year. With coffee and tea consumed daily by billions worldwide, understanding their impact on bone health ...

School feeding programs lead to modest but meaningful results

2025-12-11
Free or subsidized school meals lead to modest gains in math and school enrolment, according to a new Cochrane review that examined the global impact of school feeding programs on disadvantaged children in both high-income countries and low- and middle-income countries. The research team, led by scientists from University of Ottawa, found that providing free or subsidized meals in schools slightly improves math achievement and enrolment rates in low- and middle-income countries (LMICs), and likely contributes to small gains in physical growth indicators such as height-for-age ...

LAST 30 PRESS RELEASES:

National Reactor Innovation Center opens Molten Salt Thermophysical Examination Capability at INL

International Progressive MS Alliance awards €6.9 million to three studies researching therapies to address common symptoms of progressive MS

Can your soil’s color predict its health?

Biochar nanomaterials could transform medicine, energy, and climate solutions

Turning waste into power: scientists convert discarded phone batteries and industrial lignin into high-performance sodium battery materials

PhD student maps mysterious upper atmosphere of Uranus for the first time

Idaho National Laboratory to accelerate nuclear energy deployment with NVIDIA AI through the Genesis Mission

Blood test could help guide treatment decisions in germ cell tumors

New ‘scimitar-crested’ Spinosaurus species discovered in the central Sahara

“Cyborg” pancreatic organoids can monitor the maturation of islet cells

Technique to extract concepts from AI models can help steer and monitor model outputs

Study clarifies the cancer genome in domestic cats

Crested Spinosaurus fossil was aquatic, but lived 1,000 kilometers from the Tethys Sea

MULTI-evolve: Rapid evolution of complex multi-mutant proteins

A new method to steer AI output uncovers vulnerabilities and potential improvements

Why some objects in space look like snowmen

Flickering glacial climate may have shaped early human evolution

First AHA/ACC acute pulmonary embolism guideline: prompt diagnosis and treatment are key

Could “cyborg” transplants replace pancreatic tissue damaged by diabetes?

Hearing a molecule’s solo performance

Justice after trauma? Race, red tape keep sexual assault victims from compensation

Columbia researchers awarded ARPA-H funding to speed diagnosis of lymphatic disorders

James R. Downing, MD, to step down as president and CEO of St. Jude Children’s Research Hospital in late 2026

A remote-controlled CAR-T for safer immunotherapy

UT College of Veterinary Medicine dean elected Fellow of the American Academy of Microbiology

AERA selects 34 exemplary scholars as 2026 Fellows

Similar kinases play distinct roles in the brain

New research takes first step toward advance warnings of space weather

Scientists unlock a massive new ‘color palette’ for biomedical research by synthesizing non-natural amino acids

Brain cells drive endurance gains after exercise

[Press-News.org] Targeting collagen signaling boosts drug delivery in pancreatic cancer
Researchers reveal how blocking collagen signaling enhances treatment response by overcoming fibrotic barriers